CHINNEY KW (01556) announced its interim results, with a net profit of HK$ 45.878 million, a decrease of 26.1% year-on-year.
Jianye Jianrong (01556) announced its interim results for 2026, with revenue of approximately HKD 704 million, a year-on-year decrease of 41.61%; net profit of HKD 45.878 million, a year-on-year decrease of 26.1%; and earnings per share of HKD 0.0306.
CHINNEY KW (01556) announced its interim results for 2026, reporting a revenue of approximately HKD 704 million, a year-on-year decrease of 41.61%; net profit of HKD 45.878 million, a year-on-year decrease of 26.1%; earnings per share of HKD 0.0306.
The announcement stated that the decrease in net profit was mainly due to an increase in administrative expenses of HKD 63.4 million during the period, partially offset by an increase in gross profit of HKD 29.9 million from construction projects, an increase of HKD 5.6 million in other income and gains, and a reversal of impairment of trade receivables amounting to HKD 5.8 million for a specific customer.
Related Articles

US Stock Market Move | Kanzhun Ltd. Sponsored ADR (BZ.US) surged over 18% with Q2 revenue increasing by 14.1% year-on-year.

US Stock Market Move | The MSCI index exclusion risk strikes again, and Strategy (MSTR.US) has dropped over 4%.

MP CARDIOFLOW-B(02160) has appointed Zhang Ruinian as the company's president.
US Stock Market Move | Kanzhun Ltd. Sponsored ADR (BZ.US) surged over 18% with Q2 revenue increasing by 14.1% year-on-year.

US Stock Market Move | The MSCI index exclusion risk strikes again, and Strategy (MSTR.US) has dropped over 4%.

MP CARDIOFLOW-B(02160) has appointed Zhang Ruinian as the company's president.

RECOMMEND





